CIRRI, MARZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.422
EU - Europa 4.154
AS - Asia 3.135
SA - Sud America 611
AF - Africa 96
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.344
RU - Federazione Russa 1.448
SG - Singapore 885
IT - Italia 795
CN - Cina 724
PL - Polonia 567
BR - Brasile 490
HK - Hong Kong 413
VN - Vietnam 350
IE - Irlanda 323
KR - Corea 266
SE - Svezia 224
UA - Ucraina 177
DE - Germania 163
IN - India 157
FR - Francia 143
FI - Finlandia 115
GB - Regno Unito 80
JO - Giordania 71
ID - Indonesia 55
BD - Bangladesh 51
AU - Australia 41
AR - Argentina 40
CA - Canada 39
NL - Olanda 33
TR - Turchia 30
ES - Italia 26
JP - Giappone 24
MX - Messico 22
PK - Pakistan 22
EC - Ecuador 21
IQ - Iraq 21
CO - Colombia 17
SC - Seychelles 16
BE - Belgio 14
EG - Egitto 13
PE - Perù 11
PT - Portogallo 11
DZ - Algeria 10
MA - Marocco 10
VE - Venezuela 10
ZA - Sudafrica 10
PY - Paraguay 9
CH - Svizzera 8
CI - Costa d'Avorio 8
AZ - Azerbaigian 7
KE - Kenya 7
LT - Lituania 7
NP - Nepal 7
CL - Cile 6
NG - Nigeria 6
PH - Filippine 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 4
ET - Etiopia 4
KG - Kirghizistan 4
BJ - Benin 3
CZ - Repubblica Ceca 3
DM - Dominica 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
MY - Malesia 3
MZ - Mozambico 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
BG - Bulgaria 2
DK - Danimarca 2
LB - Libano 2
MD - Moldavia 2
MM - Myanmar 2
SV - El Salvador 2
TH - Thailandia 2
AL - Albania 1
AT - Austria 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 15.461
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.536
Ashburn 785
Fairfield 666
Singapore 626
Warsaw 562
Chandler 337
Hong Kong 328
San Jose 326
Dublin 321
Woodbridge 300
Seoul 260
Jacksonville 258
Cambridge 243
Seattle 243
Houston 232
Wilmington 196
Hefei 179
Beijing 163
Ann Arbor 135
Altamura 133
Lawrence 122
Florence 121
Ho Chi Minh City 116
The Dalles 115
Los Angeles 96
Princeton 96
Dallas 90
Lauterbourg 89
Council Bluffs 83
Hanoi 76
Boardman 75
Boston 68
Buffalo 62
Moscow 62
Rome 57
São Paulo 51
Mumbai 49
Milan 45
New York 44
San Diego 42
Melbourne 40
Helsinki 35
Medford 33
Paris 31
Jakarta 29
Kent 29
Chicago 25
Shanghai 25
Orem 24
Da Nang 23
Munich 23
Tokyo 22
West Jordan 21
Clifton 18
Auburn Hills 17
Rio de Janeiro 17
Toronto 16
Bengaluru 14
Falls Church 14
Naples 14
Brussels 13
Frankfurt Am Main 13
Modugno 13
Guangzhou 11
Haiphong 11
Izmir 11
Norwalk 11
Andover 10
Barcelona 10
Brasília 10
Catania 10
Dong Ket 10
Giza 10
London 10
Salt Lake City 10
Bari 9
Capaccio 9
Denver 9
Lappeenranta 9
Madrid 9
Manchester 9
Mexico City 9
Verona 9
Abidjan 8
Belo Horizonte 8
Lucknow 8
Monza 8
Palermo 8
Porto Alegre 8
São Bernardo do Campo 8
Tianjin 8
Vancouver 8
Atlanta 7
Baghdad 7
Baku 7
Brooklyn 7
Chennai 7
Genoa 7
Hillsboro 7
Nairobi 7
Totale 10.221
Salva come PNG Salva come JPEG
Nome #
Esercizi di ripasso 369
Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-B-cyclodextrin ternary systems 327
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 304
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 294
Development of a new delivery system consisting in "drug-in cyclodextrin- in nanostructured lipid carriers" for ketoprofen topical delivery 281
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 273
Solid lipid nanoparticles as new strategy for oral delivery of nebivolol hydrochloride 227
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System 222
Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state 220
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib 214
CHARACTERIZATION OF THE SOLID PHASES OF PARACETAMOL AND FENAMATES AT EQUILIBRIUM IN SATURATED SOLUTIONS 210
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and L-arginine aimed to improve the drug solubility 202
Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen 200
Combined use of bile acids and aminoacids to improve permeation properties of acyclovir 199
Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide, 197
A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 197
Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration 190
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation 189
Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins 188
New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs 181
Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants 180
Tecnologia Farmaceutica 178
120) Effect of cyclodextrin complexation on theophylline release from coated polymeric matrix tablets 177
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays 177
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone 171
Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery 171
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers 168
Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties 168
Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics 168
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use 167
Development and characterization of liquisolid tablets based on mesoporous clays or silicas for improving glyburide dissolution 167
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles 163
The influence of chitosan on cyclodextrin complexing and solubilizing abilities towards drugs 162
Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. 162
Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques 161
Solid state characterization of glyburide-cyclodextrin co-ground products 159
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin 159
Polymeric mucoadhesive tablets for topical or systemic buccal delivery of clonazepam: Effect of cyclodextrin complexation 159
Development of enteric-coated timed-release matrix tablets for colon targeting 155
Study of formulation variables influencing the drug release rate from matrix tablets by experimental design 153
Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique 153
Combined use of cyclodextrins and amino acids for the development of cefixime oral solutions for pediatric use 153
Niosomes Functionalized with a Synthetic Carbohydrate Binding Agent for Mannose-Targeted Doxorubicin Delivery 152
Improvement of butamben anesthetic efficacy by the development of deformable liposomes bearing the drug as cyclodextrin complex 152
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations 152
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery 150
β-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity 150
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 149
Mixture experiment methods in the development and optimization of microemulsion formulations 147
Differential Scanning calorimetry as an analytical tool in the study of drug-cyclodextrin interactions 146
Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. 145
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 144
Role of Cyclodextrins and Drug Solid State Properties on Flufenamic Acid Dissolution Performance from Tablets 144
Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with a-cyclodextrin and glycine 142
Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline 142
Mixture design in the optimization of a microemulsion system for EKC determination of ketorolac and related impurities 142
Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers 142
Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability 141
Development of mucoadhesive films for buccal administration of flufenamic acid: Effect of cyclodextrin complexation. 141
Liquid spray formulations of xibornol using self-microemulsifying drug delivery systems 141
Sustained release matrix tablets of metformin hydrochloride in combination with triacetyl-ß-cyclodextrin 141
Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants 140
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review 139
Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets 138
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization 138
Amine-and amino acid-based compounds as carbonic anhydrase activators 138
Optimization of glibenclamide tablet composition through the combined use of Differential Scanning Calorimetry and D-optimal mixture experimental design. 136
Dissolution and permeation properties of Naproxen from solid-state systems with chitosan 135
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery 134
Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems 134
Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations 133
Physical chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin 133
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 131
Development and evaluation of an in vitro method for prediction of human drug absorption: II. Demonstration of the method suitability 129
Development of fast-dissolving tablets of flurbiprofen- cyclodextrin complexes 128
Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids 127
INVESTIGATION OF THE EFFECTS OF GRINDING AND CO-GRINDING ON PHYSISCOCHEMICAL PROPERTIES OF GLISENTIDE 126
Development of a stable oral pediatric solution of hydrochlorothiazide by the combined use of cyclodextrins and hydrophilic polymers 121
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components 121
Effects of cyclodextrins and chitosan on gliburide dissolution and permeability through intestinal epithelial cells (Caco 2) 120
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-ß-cyclodextrin complex 118
Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems 116
Preparation of glyburide nanocrystals with improved dissolution properties by dry-ball- and wet-bead- milling: Systematic comparison by experimental design of the performance of the two methods. 116
Influence of solvent composition on the solid phase at equilibrium with saturated solutions of quinolones in different sovent mixtures 114
Principi di calcolo farmaceutico 113
Innovative formulazioni liquide a base di propranololo a confronto con le attuali formulazioni nella terapia pediatrica 113
Development of a sustained-release matrix tablet formulation of DHEA as ternary complex with alpha-cyclodextrin and glycine 112
Development and microbiological evaluation of chitosan and chitosan-alginate microspheres for vaginal administration of metronidazole 110
Development of a Hydroxypropyl-beta -Cyclodextrin-based liquid formulation for the oral administration of propranolol in pediatric therapy 107
Proprietà biofarmaceutiche e problemi di biodisponibilità: test in vitro 107
Development and evaluation of an in vitro method for prediction of human drug absorption: I. Assessment of artificial membrane composition. 105
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 98
Physicochemical characterization of DHEA-cyclodextrin-glycine ternary systems 93
Curcumin’s niosomes coated with chitosan for the treatment of osteoarthritis: effect of cyclodextrin complexation 92
Quality by Design approach for developing Chitosan-Ca-alginate microspheres for colon delivery of Celecoxib-hydroxypropyl-beta-cyclodextrin-PVP complex. 91
Les plans d’experiences des melanges dans l’optimisation d’un systeme de microemulsion par l’analyse d’electrophorese capillaire-Mixture design in the optimization of a microemulsion system for capillary electrophoresis analysis 91
Experimental design in the study of microemulsions. Use of a new oil phase for MEEKC analysis 88
Ternary systems of naproxen with hydroxypropyl-ß-cyclodextrin and aminoacids 80
Pediatric Orally Disintegrating Tablets (ODTs) with Enhanced Palatability Based on Propranolol HCl Coground with Hydroxypropyl-β-Cyclodextrin 77
On-body drug delivery systems: State-of-the-art technologies, clinical application, and future perspectives 66
Totale 15.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/2022627 35 56 84 12 15 30 54 37 34 15 109 146
2022/20231.574 144 321 42 132 121 262 211 68 181 23 43 26
2023/2024679 33 64 108 36 39 40 41 171 9 54 39 45
2024/20254.200 142 416 284 572 1.345 494 82 206 189 120 216 134
2025/20264.892 439 833 512 446 536 207 533 295 562 277 193 59
Totale 15.642